Improve walking balance and attention
- Trial ID
- NCT06444685
- Official Title
- Motor and Cognitive Effects of Table Tennis on Parkinson's Disease: Pilot Controlled Trial
- Goal
- Improve walking balance and attention
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Universitat de Lleida
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Parkinson Disease
- Interventions
- Exercise and cognitive training interventino
Summary For Families
It tests whether regular table tennis can improve motor problems like balance, walking, and arm control, while also helping thinking skills such as attention, reaction time, and multitasking in people with early to mid-stage Parkinson's. The approach uses guided table tennis sessions that combine aerobic movement, repetitive arm and trunk use, hand-eye coordination, and fast decision making, activities that may boost motor control and cognitive processing through practice and increased brain blood flow, and it is meant to add to, not replace, usual medications like levodopa. The trial is looking for people aged 40 to 80 with Parkinson's at Hoehn and Yahr stages I to III who can walk 10 minutes unassisted, and excludes those with significant cognitive impairment (MMSE < 23), major vision or hearing loss, serious cardiac limits to exercise, or prior brain surgery.
Locations
- Institut de Recerca Biomèdica de Lleida, Lleida, Spain
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Exercise and cognitive training interventino. It tests whether regular table tennis can improve motor problems like balance, walking, and arm control, while also helping thinking skills such as attention, reaction time, and multitasking in people with early to mid-stage Parkinson's. The approach uses guided table tennis sessions that combine aerobic movement, repetitive arm and trunk use, hand-eye coordination, and fast decision making, activities that may boost motor control and cognitive processing through practice and increased brain blood flow, and it is meant to add to, not replace, usual medications like levodopa. The trial is looking for people aged 40 to 80 with Parkinson's at Hoehn and Yahr stages I to III who can walk 10 minutes unassisted, and excludes those with significant cognitive impairment (MMSE < 23), major vision or hearing loss, serious cardiac limits to exercise, or prior brain surgery.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 9 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.